发明名称 ENZYME INHIBITORS
摘要 Compounds of of formula (I), are aurora kinase inhibitors:wherein X is -N-, -CH<SUB>2</SUB>-N-, -CH<SUB>2</SUB>-CH-, or -CH-; R<SUB>1</SUB> is a radical of formula (IA) wherein Z is -CH<SUB>2</SUB>-, -NH-, -0-, -S(O)- -S-, -S(O)<SUB>2</SUB> or a divalent monocyclic carbocyclic or heterocyclic radical having 3-7 ring atoms; Alk is an optionally substituted divalent C<SUB>1</SUB>-C<SUB>6</SUB> alkylene radical; A is hydrogen or an optionally substituted monocyclic carbocyclic or heterocyclic ring having 5-7 ring atoms; r, s and t are independently 0 or 1, provided that when A is hydrogen then at least one of r and s is 1; R<SUB>2</SUB> is halogen, -CN, -CF<SUB>3</SUB>, -OCH<SUB>3</SUB>, or cyclopropyl; and R<SUB>3</SUB> is a radical of formula (IB) wherein Q is hydrogen or an optionally substituted phenyl or monocyclic heterocyclic ring with 5 or 6 ring atoms; Z<SUP>1</SUP> is -S-, -S(O)-, -S(O)<SUB>2</SUB>-, -O-, -SO<SUB>2</SUB>NH-, -NHSO<SUB>2</SUB>-, NHC(=O)NH, -NH(C=S)NH-, Or -N(R<SUB>4</SUB>)- wherein R<SUB>4</SUB> is hydrogen, C<SUB>1</SUB>-C<SUB>3</SUB> alkyl, cycloalkyl, or benzyl; and Alk<SUP>1</SUP> and Alk<SUP>2</SUP> are, independently, optionally substituted divalent C<SUB>1</SUB>-C<SUB>3</SUB> alkylene radicals; and m, n and p are independently 0 or 1.
申请公布号 WO2007072017(A3) 申请公布日期 2007.08.16
申请号 WO2006GB04854 申请日期 2006.12.21
申请人 CHROMA THERAPEUTICS LTD.;BAVETSIAS, VASSILIOS;MACDONALD, EDWARD;LINARDOPOULOS, SPYRIDON 发明人 BAVETSIAS, VASSILIOS;MACDONALD, EDWARD;LINARDOPOULOS, SPYRIDON
分类号 C07D471/04;A61K31/437;A61P37/08 主分类号 C07D471/04
代理机构 代理人
主权项
地址